US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Northwest Biotherapeutics, Inc.

0.2550

-0.0006-0.25%

Volume:1.69M

Turnover:429.14K

Market Cap:405.51M

PE:-3.91

High:0.2599

Open:0.2599

Low:0.2500

Close:0.2557

52wk High:0.4788

52wk Low:0.1685

Shares:1.59B

Float Shares:1.55B

Volume Ratio:0.59

T/O Rate:0.11%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.0652

EPS(LYR):-0.0575

ROE:276.45%

ROA:-135.39%

PB:-3.73

PE(LYR):-4.43

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Northwest Biotherapeutics Cancels 17% of 2020 Management Options

Northwest Biotherapeutics Inc. held annual shareholder meeting

Northwest Biotherapeutics Secures $5 Million Convertible Loan from Yorkville Advisors

Northwest Biotherapeutics Announces That Construction Activities Are Under Way for the First Grade C Manufacturing Suite in the Sawston, UK Facility

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/NWBO"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NWBO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NWBO\",,,,,undefined,":{"symbol":"NWBO","market":"US","secType":"STK","nameCN":"Northwest Biotherapeutics, Inc.","latestPrice":0.255,"timestamp":1770411600000,"preClose":0.25565,"halted":0,"volume":1688238,"delay":15,"changeRate":-0.002542538627029079,"floatShares":1553210415,"shares":1590242390,"eps":-0.065174,"marketStatus":"Market Closed","change":-0.00065,"latestTime":"02-06 16:00:00 EST Delay","open":0.2599,"high":0.2599,"low":0.25,"amount":429143.4178359995,"amplitude":0.038725,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-0.065174,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1770627600000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"OTCQB","adjPreClose":0.25565,"volumeRatio":0.5860241692316109},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NWBO\",,,,,undefined,":{"symbol":"NWBO","floatShares":1553210415,"roa":"-135.39%","roe":"276.45%","lyrEps":-0.057517,"volumeRatio":0.5860241692316109,"shares":1590242390,"dividePrice":0,"high":0.2599,"amplitude":0.038725,"preClose":0.25565,"low":0.25,"week52Low":0.16845,"pbRate":"-3.73","psRate":"432.78","week52High":0.4788,"institutionHeld":0.001,"latestPrice":0.255,"eps":-0.065174,"divideRate":0,"volume":1688238,"delay":15,"ttmEps":-0.065174,"open":0.2599,"prevYearClose":0.22875,"prevWeekClose":0.2909,"prevMonthClose":0.2909,"prevQuarterClose":0.2288,"fiveDayClose":0.2909,"twentyDayClose":0.26,"sixtyDayClose":0.2481},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NWBO\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-11-12","symbol":"NWBO","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2024-08-09","symbol":"NWBO","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1723176000000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2024-05-10","symbol":"NWBO","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1715313600000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2024-03-05","symbol":"NWBO","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1709614800000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2023-11-09","symbol":"NWBO","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1699506000000,"reportTimeType":"post","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NWBO\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NWBO\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NWBO\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2603936701","title":"Northwest Biotherapeutics Cancels 17% of 2020 Management Options","url":"https://stock-news.laohu8.com/highlight/detail?id=2603936701","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603936701?lang=en_us&edition=fundamental","pubTime":"2026-01-16 06:06","pubTimestamp":1768514809,"startTime":"0","endTime":"0","summary":"Northwest Biotherapeutics Inc. has announced the cancellation of 17% of the challenged 2020 option awards to company management and directors as part of a settlement agreement related to litigation in the Delaware Court of Chancery. Under the terms of the settlement, the company’s insurance carriers will pay $2.25 million to the company, and all claims between the parties will be fully resolved.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Northwest Biotherapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on January 15, 2026, and is solely responsible for the information contai","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260115:nNDL8GNvtN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NWBO","BK4139"],"gpt_icon":0},{"id":"2600109531","title":"Northwest Biotherapeutics Inc. held annual shareholder meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2600109531","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2600109531?lang=en_us&edition=fundamental","pubTime":"2026-01-03 06:15","pubTimestamp":1767392144,"startTime":"0","endTime":"0","summary":"Northwest Biotherapeutics Inc. held its annual meeting of stockholders on December 29, 2025. At the meeting, shareholders approved the election of Pat Sarma to the Board of Directors. The appointment of Cherry Bekaert LLP as independent registered public accounting firm for the fiscal year ending December 31, 2025 was also ratified. In addition, shareholders approved an amendment to increase the number of authorized shares of common stock from 1.7 billion to 2.6 billion.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Northwest Biotherapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commissio","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260102:nNDL6psf1F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NWBO"],"gpt_icon":0},{"id":"2585215019","title":"Northwest Biotherapeutics Secures $5 Million Convertible Loan from Yorkville Advisors","url":"https://stock-news.laohu8.com/highlight/detail?id=2585215019","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585215019?lang=en_us&edition=fundamental","pubTime":"2025-11-21 05:26","pubTimestamp":1763673997,"startTime":"0","endTime":"0","summary":"Northwest Biotherapeutics Inc. has entered into a $5 million convertible promissory note financing agreement with YA II PN, Ltd., an investment fund managed by Yorkville Advisors Global, LP. The proceeds from this financing will be used to help cover construction and equipment costs for the company's first Grade C manufacturing suite at its Sawston, UK facility, as well as for ongoing operations. The note has a 12-month term, with no payments due until maturity, carries a five percent original issue discount but no interest, and may be converted at the option of the holder at a small discount to the prevailing market price, subject to monthly conversion limits unless the conversion price exceeds $0.29.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251120:nNDLbMYlpQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NWBO"],"gpt_icon":0},{"id":"2585152693","title":"Northwest Biotherapeutics Announces That Construction Activities Are Under Way for the First Grade C Manufacturing Suite in the Sawston, UK Facility","url":"https://stock-news.laohu8.com/highlight/detail?id=2585152693","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585152693?lang=en_us&edition=fundamental","pubTime":"2025-11-21 03:58","pubTimestamp":1763668719,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251120:nTUA1S6Q3P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NWBO","BK4139"],"gpt_icon":0}],"pageSize":4,"totalPage":5,"pageCount":1,"totalSize":18,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/NWBO\",params:#limit:6,delay:false,,,undefined,":[]}}